Secondary data | Primary data | 95% Confidence interval | Test-statistic | ||
---|---|---|---|---|---|
Variable-level | GER (θ1) | BCQDB (θ2) | Lower bound (θ2) | Upper bound (θ2) | p-value |
00-49 years | 21.4 | 24.4 | 19.4 | 30.1 | ns |
50-69 years | 50.5 | 43.6 | 37.6 | 49.8 | 0.024 |
≥ 70 years | 28.1 | 32.0 | 26.4 | 37.9 | ns |
pTis (non-invasive) | 4.3 | 4.5 | 2.4 | 7.7 | ns |
pT1 (≤ 2cm) | 47.4 | 53.0 | 46.8 | 59.1 | ns |
pT2 (≤ 5cm) | 35.8 | 30.8 | 25.3 | 36.8 | ns |
pT3 (> 5cm) | 4.7 | 2.6 | 1.1 | 5.3 | ns |
pT4 (involving other areals) | 7.8 | 9.0 | 5.9 | 13.1 | ns |
pN+ | 37.0 | 32.7 | 27.1 | 38.7 | ns |
Involved lymph nodes 0 | 60.9 | 63.4 | 57.0 | 69.6 | ns |
Involved lymph nodes 1-3 | 20.1 | 19.3 | 14.5 | 24.9 | ns |
Involved lymph nodes 4-9 | 11.8 | 10.5 | 6.9 | 15.1 | ns |
Involved lymph nodes >10 | 7.2 | 6.7 | 3.9 | 10.7 | ns |
Stage 0 | 4.2 | 4.5 | 2.4 | 7.7 | ns |
Stage 1 | 36.0 | 38.7 | 32.8 | 44.9 | ns |
Stage 2a | 28.5 | 27.8 | 22.5 | 33.6 | ns |
Stage 2b | 16.4 | 12.0 | 8.4 | 16.6 | ns |
Stage 3a | 4.2 | 2.3 | 0.8 | 4.8 | ns |
Stage 3b | 6.3 | 8.6 | 5.6 | 12.7 | ns |
Stage 4 | 4.5 | 6.0 | 3.5 | 9.6 | ns |
Grading 1 (G1) | 11.3 | 7.9 | 4.9 | 11.9 | ns |
Grading 2 (G2) | 55.8 | 43.3 | 37.1 | 49.6 | <0.001 |
Grading 3 (G3) | c32.9 | 48.8 | 42.5 | 55.1 | <0.001 |
ERPR+ | 82.0 | 83.5 | 78.4 | 87.7 | ns |
Variable-level | GKR (θ1) | BCQDB (θ2) | Lower bound (θ2) | Upper bound (θ2) | p-value |
00-49 years | 20.4 | 24.4 | 19.4 | 30.1 | ns |
50-69 years | 49.0 | 43.6 | 37.6 | 49.8 | ns |
≥ 70 years | 30.6 | 32.0 | 26.4 | 37.9 | ns |
Left side | 50.6 | 56.0 | 49.8 | 62.1 | ns |
Right side | 47.7 | 44.0 | 37.9 | 50.2 | ns |
Breast quadrant I | 48.6 | 46.6 | 40.5 | 52.8 | ns |
Breast quadrant II | 12.3 | 11.3 | 7.7 | 15.7 | ns |
Breast quadrant III | 9.1 | 11.7 | 8.1 | 16.1 | ns |
Breast quadrant IV | 5.6 | 8.6 | 5.6 | 12.7 | ns |
Multifocal | 16.6 | 17.3 | 12.9 | 22.4 | ns |
Mamille | 7.8 | 4.5 | 2.4 | 7.7 | 0.045 |
Non-invasive tumor | 5.8 | 4.5 | 2.4 | 7.7 | ns |
Stage 0 | 6.1 | 4.5 | 2.4 | 7.7 | ns |
Stage 1 | 38.4 | 38.7 | 32.8 | 44.9 | ns |
Stage 2 | 41.9 | 39.8 | 33.9 | 46.0 | ns |
Stage 3 | 8.0 | 10.9 | 7.4 | 15.3 | ns |
Stage 4 | 5.6 | 6.0 | 3.5 | 9.6 | ns |
Stage 0 | 0–49 years | 7.0 | 7.7 | 2.5 | 17.0 | ns |
Stage 1 | 0–49 years | 38.0 | 36.9 | 25.3 | 49.8 | ns |
Stage 2 | 0–49 years | 43.7 | 46.2 | 33.7 | 59.0 | ns |
Stage 3 | 0–49 years | 6.5 | 6.2 | 1.7 | 15.0 | ns |
Stage 4 | 0–49 years | 4.8 | 3.1 | 0.4 | 10.7 | ns |
Stage 0 | 50–69 years | 6.9 | 4.3 | 1.4 | 9.8 | ns |
Stage 1 | 50–69 years | 39.4 | 41.4 | 32.3 | 50.9 | ns |
Stage 2 | 50–69 years | 41.0 | 42.2 | 33.1 | 51.8 | ns |
Stage 3 | 50–69 years | 7.7 | 6.9 | 3.0 | 13.1 | ns |
Stage 4 | 50–69 years | 5.0 | 5.2 | 1.9 | 10.9 | ns |
Stage 0 | ≥70 years | 4.1 | 2.4 | 0.3 | 8.2 | ns |
Stage 1 | ≥70 years | 36.9 | 36.5 | 26.3 | 47.6 | ns |
Stage 2 | ≥70 years | 42.2 | 31.8 | 22.1 | 42.8 | ns |
Stage 3 | ≥70 years | 9.7 | 20.0 | 12.1 | 30.1 | <0.001 |
Stage 4 | ≥70 years | 7.1 | 9.4 | 4.2 | 17.7 | ns |